An Autocrine Role for CXCL1 in Progression of Hepatocellular Carcinoma

Background: One of the most prevalent causes of cancer fatalities is hepatocellular carcinoma (HCC), which has been linked to metabolic syndrome. Circulating levels of the saturated fatty acid palmitate are elevated in metabolic syndrome and lead to cellular stress. Materials and Methods: Using enzy...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2020-11, Vol.40 (11), p.6075-6081
Main Authors: DAHLQUIST, KORBYN J.V., VOTH, LAURA C., FEE, AMANDA J., STOECKMAN, ANGELA K.
Format: Article
Language:English
Subjects:
Apoptosis
Assaying
Autocrine signalling
Cancer
Cell migration
Cellular stress response
Chemokines
CXCR2 protein
Enzyme-linked immunosorbent assay
Fatty acids
Flow cytometry
Hepatocellular carcinoma
Hepatoma
Liver cancer
Metabolic disorders
Metabolic syndrome
Metastases
Palmitic acid
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: One of the most prevalent causes of cancer fatalities is hepatocellular carcinoma (HCC), which has been linked to metabolic syndrome. Circulating levels of the saturated fatty acid palmitate are elevated in metabolic syndrome and lead to cellular stress. Materials and Methods: Using enzyme-linked immunosorbent assay, flow cytometry, and migration assays, we characterized the response of rat hepatoma cells to palmitate treatment. Results: We detected a 60% increase in secretion of C-X-C motif ligand 1 (CXCL1) which was dose-dependent and coincided with apoptosis. We measured expression of C-X-C motif chemokine receptor 2 (CXCR2) and observed a 4.5-fold increase on apoptotic hepatoma cells. Furthermore, we assayed migration of hepatoma cells and saw a 2-fold increase in the number of migrating cells towards CXCL1. Conclusion: These findings suggest that HCC cells secrete CXCL1 in response to metabolic syndrome signals and may promote the progression of cancer through apoptosis recovery or metastasis.
ISSN:0250-7005
1791-7530
DOI:10.21873/anticanres.14628